MNKD Mannkind Corp Losses Due To A Broker?

S

MannKind Corp. reached a high of about $56 per share in 2014. From there the stock crashed through all moving averages and showed relative weakness all the way down. If your broker held this stock and had no exit strategy and failed to limit your losses you may have a valid claim. Any proper trade plan has risk management and an exit strategy.

Soreide Law Group is representing clients who bought Mannkind Corp., against their financial professionals who recommended MannKind Corp., in large concentrated positions. MNKD may have been unsuitable for some investors and some brokers may have failed to limit losses as the company crashed. Soreide Law Group has already filed one claim against a National Securities broker for recommending MannKind Corp., to his clients and are interested in speaking with other investors who purchased the stock at any firm with any stock broker.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes.

The company was founded in 1991 and is headquartered in Westlake Village, California. MNKD stock hit a high over $50 in July of 2014 and dropped down to under $5 today. That’s an over 90% drop from high to low. Many stock brokers recommended to their clients to stay the course but that was an ill advised strategy that left many with huge stock losses they will never recover from. If you lost more than $50,000 in MannKind Corporation due to your stock brokers recommendation call 888-760-6552. Soreide Law Group is a securities arbitration firm that handles FINRA arbitrations nationwide against financial professionals. If you bought this stock on your own through a self directed trading platform we cannot assist you but if your broker recommended MNKD please contact us today.

Recent Posts

June 26, 2026

Alan Ngo Of PFS Investments Inc. Barred By FINRA For Refusing To Testify In Investigation

FINRA barred securities broker Alan K. Ngo [CRD: 4273116, Freehold, New Jersey], given the publicly available information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Ngo worked for PFS Investments Inc. from January 2, 2003, to November 25, 2025. See below to learn more about Ngo’s disclosures. FINRA Sanctioned Ngo For Failing To Comply During Investigation […]

June 26, 2026

Kevin McCarthy Of Madison Avenue Securities Barred By FINRA For Failure To Comply

FINRA barred securities broker Kevin Christopher McCarthy [CRD: 1702715, Hialeah, Florida], and investors complained about him, based on public information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. McCarthy worked for Madison Avenue Securities LLC from December 4, 2007, to January 30, 2026. Investors are encouraged to continue reading to find out more about McCarthy’s […]

June 26, 2026

Mohammed Karim Of Truist Investment Services Barred Following FINRA Investigation

FINRA barred securities broker Mohammed Anayet Karim [CRD: 4419277, Lakeland, Florida], according to publicly available information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Karim worked for BB&T Securities LLC from September 24, 2018, to February 17, 2021, and Truist Investment Services Inc. from February 17, 2021, to August 8, 2025. See the following information to […]

Contact us Nationwide USA

2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062

Phone: 1-888-760-6552
Fax: 1-954-760-6553
Email: info@securitieslawyer.com

Helping clients recover money across the USA